De interés

02 jul. 2019

BC Partners to Acquire Synthon International Holding B.V.

BC Partners to Acquire Synthon International Holding B.V., a Global Market Leader in the Development of Complex Generics

más información
05 oct. 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

Synthon today announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-filled syringe for the treatment of relapsing forms of multiple sclerosis…

más información
13 sept. 2017

European Patent Office decides in Synthon’s favor in glatiramer patent case

On 12 September, in opposition proceedings filed by inter alia Synthon, the Technical Board of Appeal (TBA) of the European Patent Office revoked the last of Teva's three glatiramer so-called HBr…

más información
More news

Synthon en el mundo